Published in Clin J Am Soc Nephrol on December 01, 2011
Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int (2012) 1.82
A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation (2016) 0.79
FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde. Clin Kidney J (2016) 0.75
Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation. Biomed Res Int (2015) 0.75
Mineral and bone disorder after kidney transplantation. World J Transplant (2015) 0.75
Beneficial effects of preemptive kidney transplantation on calcium and phosphorus disorders in early post-transplant recipients. Clin Exp Nephrol (2014) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med (2008) 9.19
Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr (2008) 7.61
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res (2003) 6.81
Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol (2004) 6.59
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol (2005) 5.76
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol (2007) 4.59
The parathyroid is a target organ for FGF23 in rats. J Clin Invest (2007) 4.47
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int (2003) 3.75
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res (2006) 3.66
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int (2010) 3.04
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis (2005) 2.82
NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med (2008) 2.70
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol (2007) 2.31
FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int (2004) 1.74
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int (2006) 1.45
Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant (2007) 1.32
Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol (2010) 1.21
Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med (2008) 1.20
Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler Thromb Vasc Biol (2009) 1.18
Vitamin D status in renal transplant recipients. Am J Transplant (2007) 1.13
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol (2008) 1.07
Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr (2008) 1.01
Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation (2009) 1.00
The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study. Nephrol Dial Transplant (2011) 0.90
Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol (2007) 0.88
Posttransplant bone disease: evidence for a high bone resorption state. Transplantation (2000) 0.86
Rapamycin-induced hypophosphatemia and insulin resistance are associated with mTORC2 activation and Klotho expression. Am J Transplant (2011) 0.84
Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia. Clin Exp Nephrol (2007) 0.80
Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol. Miner Electrolyte Metab (1986) 0.78
Misconceptions IV--the hypophosphatemia of primary hyperparathyroidism is the result of renal phosphate wasting. Bone (2004) 0.78
Prospective study of calcium homeostasis after renal transplantation. World J Surg (1998) 0.77
Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Clin Nephrol (2001) 0.76
Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol (2005) 1.76
Outcomes and predictive factors of pediatric kidney transplants: an analysis of the Thai Transplant Registry. Pediatr Transplant (2013) 1.44
A 25-year experience of kidney transplantation in Thailand: report from the Thai Transplant Registry. Nephrology (Carlton) (2015) 1.42
Functional significance of prorenin internalization in the rat heart. Circ Res (2002) 1.08
Alcohol, illicit and non-illicit psychoactive drug use and road traffic injury in Thailand: a case-control study. Accid Anal Prev (2009) 1.06
Evidence-based medicine in clinical curriculum. Ann Acad Med Singapore (2006) 1.04
Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin Infect Dis (2003) 0.98
Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant (2010) 0.97
Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis. Kidney Int (2002) 0.96
Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney Int (2004) 0.96
Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant (2008) 0.95
Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis. Transplantation (2013) 0.92
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient. Southeast Asian J Trop Med Public Health (2013) 0.90
Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res (2003) 0.89
Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis (2006) 0.87
Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Leuk Res (2006) 0.87
Angiotensin-converting enzyme is a modifier of hypertensive end organ damage. J Biol Chem (2009) 0.85
Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. J Autoimmun (2005) 0.85
Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR 106-01 cells. Kidney Int (2002) 0.84
Connective tissue growth factor gene expression and decline in renal function in lupus nephritis. Exp Ther Med (2012) 0.84
A simplified clinical prediction score of chronic kidney disease: a cross-sectional-survey study. BMC Nephrol (2011) 0.84
Overview of lupus nephritis management guidelines and perspective from Asia. Int J Rheum Dis (2013) 0.83
Metabolic acidosis lowers circulating adiponectin through inhibition of adiponectin gene transcription. Nephrol Dial Transplant (2010) 0.83
Overview of lupus nephritis management guidelines and perspective from Asia. Nephrology (Carlton) (2014) 0.83
The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int (2012) 0.83
Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant (2004) 0.82
Incomplete renal tubular acidosis and bone mineral density: a population survey in an area of endemic renal tubular acidosis. Nephrol Dial Transplant (2004) 0.81
Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients. BMC Nephrol (2013) 0.81
Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease. J Pediatr Endocrinol Metab (2008) 0.80
Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis. Medicine (Baltimore) (2010) 0.80
Low hip bone mineral density predicts mortality in maintenance hemodialysis patients: a five-year follow-up study. Blood Purif (2014) 0.80
Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT study): rationale and design of the study [NCT01978951]. BMC Nephrol (2014) 0.79
Clinical analysis of adult-onset spinocerebellar ataxias in Thailand. BMC Neurol (2014) 0.79
Safety riding program and motorcycle-related injuries in Thailand. Accid Anal Prev (2013) 0.78
Prognostic factors of all-cause mortalities in continuous ambulatory peritoneal dialysis: a cohort study. BMC Nephrol (2013) 0.78
Proteomic profiles of mesenchymal stem cells induced by a liver differentiation protocol. Int J Mol Sci (2010) 0.78
Pre-transplant donor specific antibody and its clinical significance in kidney transplantation. Asian Pac J Allergy Immunol (2012) 0.78
Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study. J Med Assoc Thai (2006) 0.77
Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen. Maturitas (2002) 0.77
Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study. Medicine (Baltimore) (2015) 0.77
Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies. Clin Rheumatol (2007) 0.77
Thyroid hormone increases mRNA and protein expression of Na+-K+-ATPase alpha2 and beta1 subunits in human skeletal muscles. J Clin Endocrinol Metab (2006) 0.76
Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway. Clin Rheumatol (2006) 0.76
Use of in vivo gene expression of isolated bone marrow mesenchymal stromal cells to study the pathophysiology of osteoporosis in patients with severe thalassemia. J Pediatr Hematol Oncol (2011) 0.76
Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency. J Med Assoc Thai (2010) 0.76
High collagen I gene expression as an independent predictor of adverse renal outcomes in lupus nephritis patients with preserved renal function. Arch Pathol Lab Med (2015) 0.76
Vascular calcification in long-term kidney transplantation. Nephrology (Carlton) (2014) 0.75
Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients. Am J Kidney Dis (2002) 0.75
Alteration of noncollagenous bone matrix proteins in distal renal tubular acidosis. Bone (2004) 0.75
Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis. Kidney Blood Press Res (2016) 0.75
The 10th congress of the Asian Society of Transplantation--Part I. Preface. Transplant Proc (2008) 0.75
Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients. Asian Pac J Allergy Immunol (2015) 0.75
Transient Elastography in End-Stage Renal Disease Patients on Hemodialysis: The Effect of Net Fluid Withdrawal. Blood Purif (2015) 0.75
Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient. J Med Assoc Thai (2006) 0.75
Cystine urinary lithiasis in Thailand: a report of five cases. J Med Assoc Thai (2003) 0.75
Survival analysis for respiratory failure in patients with food-borne botulism. Clin Toxicol (Phila) (2010) 0.75
Electrodiagnosis of botulism and clinico-electrophysiological correlation. Clin Neurophysiol (2009) 0.75
The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis. J Med Assoc Thai (2002) 0.75
Efficacy and safety of enoxaparin during hemodialysis: results from the HENOX study. J Med Assoc Thai (2011) 0.75